Search results
365 results found
Identification and genomic dataReportGenomic data does not sit comfortably within the current legal and regulatory framework as a consequence of its nature and an overall lack of regulatory coherence. We explain the complex debate and regulatory issues
Developing effective ctDNA testing services for lung cancerReportOur report outlines the most pressing issues affecting the implementation and provision of ctDNA testing services for lung cancer and describes the early experiences of some of the laboratories
Linking and sharing routine health data for researchReportThe recommendations are drawn from a series of interviews with experienced data users on the complex issues of using de-identified data, the barriers and the ways to improve data sharing for research.
Polygenic scores, risk and cardiovascular diseaseReportPublished in 2019, this reports examines the evidence and readiness for clinical implementation of polygenic scores from the perspective of cardiovascular disease prevention.
Synthetic health data, real regulatory challengeBlogSynthetic health data is a new form of data generation which demands new regulatory approaches to deliver the benefits to patient care we all would like to see, argues Dr Colin Mitchell
PHG commentary: ACMG statement on clinical application of polygenic risk scoresBlogThe ACMG has provided a useful and timely reminder, and much needed clarity, that there is some way to go before polygenic scores can be used routinely in healthcare.
Revealing the history of genetics and genomics policy in BritainBlogThe PHG Foundation hosts showcase for new book on the history of policy supporting genetics and genomics
Sequencing monkeypoxBlogOver the weekend the WHO declared the monkeypox outbreak a “public health emergency of international concern”.